VR AI Meditation for Pain
ConditionPain and Anxiety
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChristopher Almario
About this trial
This study aims to assess changes in pain and anxiety as reported by the Pain Numeric Rating Scale (PNRS) and the State-Trait Anxiety Inventory 6 (STAI-6), pre and post a guided meditation in Virtual reality. Objectives of the study are also to determine the feasibility, and patient acceptance of utilizing a LLM-generated guided meditation in VR. Our goal is to learn about any limitations of our approach and provide a pathway for future improvements in creating a VR AI therapist that is optimally aligned with the needs of users.
Eligibility criteria
Qualifiers
18+ years of age
Individuals who are admitted to CSMC and who have completed the Inpatient Pain Service Center intake form.
Participants must speak one of the program's supported languages (currently English and Spanish)
Minimum pain score of 4 out 10 on baseline pain survey
Disqualifiers
Unwilling and/or unable to participate
Does not understand English or Spanish
Self-reported history of severe motion sickness
The presence of a facial/head deformity that will prohibit the wearing of a VR HMD
Trial design
Treatments tested in this trial
- VR Guided Meditation
Treatment groups
38 Participants
are divided into 1 treatment groupSponsors and collaborators
Christopher Almario
Lead sponsor
Cedars-Sinai Medical Center
Sponsor institution
Source ClinicalTrials.gov